🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro KwikPen vs vial — looking for input Page 3

Mounjaro KwikPen vs vial — looking for input

tony_orlando Sat, Oct 19, 2024 at 1:14 AM 33 replies 2,392 viewsPage 3 of 7
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Oct 21, 2024 at 7:41 PM#11
pat_auckland said:
SURMOUNT-1 landed around 20.9% mean weight loss at 15mg over 72 weeks, against roughly 15% for semaglutide 2.4mg in STEP 1.

Bookmarking. The distinction being drawn above is the one nobody else makes.

Last edited: Oct 21, 2024 at 11:41 PM
40 13andrew_nyc, Dr.EndoEP, GraceAZ_72 and 37 others
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Oct 22, 2024 at 7:33 AM#12

Adding the clinical framing, because it changes how the question reads. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Happy to go further on any of that.

Last edited: Oct 22, 2024 at 11:33 AM
41 14matt_MKE, Dr.ReproEndo, lucas_SP_BR and 38 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Oct 22, 2024 at 7:25 PM#13
paige_pharma said:
It is worth asking what the claim would look like if it were false.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

Last edited: Oct 23, 2024 at 12:25 AM
42 15adam_van, Dr.SurgeonPGH, rachel_ABQ and 39 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Oct 23, 2024 at 7:17 AM#14

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Oct 23, 2024 at 10:17 AM
43 16jennifer_SEA, tyler_CSCS, VanRx_Mike and 40 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Oct 23, 2024 at 7:10 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. No action needed from anybody.

44 17PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 41 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register